• Home
    • StockRanks™
    • Platform
        • Research & Discuss
        • Editorial & Community
        • Learn & Improve
        • Webinars & Masterclasses
        • Stockopedia Academy
    • Reviews
    • Pricing
    Get startedLog in
    SectorsHealthcareBiotechnology & Medical ResearchRespirerx Pharmaceuticals
    Picture of Respirerx Pharmaceuticals logo

    RSPI — Respirerx Pharmaceuticals Share News

    $0.000.000.00%
    us flag iconLast trade - 00:00
    HealthcareHighly SpeculativeMicro Cap
    • Market Cap
      $0.66m
    • Enterprise Value
      $3.80m
    • Revenue
    • Quality
    • Value
    • Momentum
    • StockRank™
    • StockReport™
    • Accounts
      • Balance sheet
      • Income statement
      • Cashflow statement
      • Dividend summary
    • News
    • RSPI Dividends
    StockReport™
    Balance sheet
    Income statement
    Cashflow
    News
    RSPI Dividends
    • Brief: Respirerx Pharmaceuticals Announces That CFO Jeff Margolis Is Presenting At The Investor Summit

      10/11/2022 15:13
    • NZ's EROAD eyes best day in over 3 weeks on clearance for Cortex acquisition

      18/11/2021 02:34
    • Brief: Respirerx Pharma Says Sent Formal Notice To Board Of Therapix Biosciences

      30/07/2019 14:14
    • Brief: Respirerx Pharmaceuticals updates on ops, liquidity situation

      25/08/2017 15:55

    Company

    • About us
    • Careers
    • Product Guide

    Our Coverage

    • Countries
    • Sectors
    • Ratios

    Top Stocks

    • UK Stocks
    • Australian Stocks
    • US Stocks

    Legals

    • Privacy Policy
    • Terms & Conditions
    • Disclaimer & FSG
    • Cookies
    Trustpilot
    Select a country/region:


    © Stockopedia 2026, Refinitiv, Share Data Services.

    *Past performance is no indicator of future performance, and testimonials are provided by third parties for informational purposes only and are not intended and should not be taken to be financial product advice. Performance returns are based on hypothetical scenarios and do not represent an actual investment.

    This site cannot substitute for professional investment advice or independent factual verification. To use Stockopedia, you must accept our Terms of use, Privacy and Disclaimer & FSG. All services are provided by Stockopedia Ltd, United Kingdom (company number 06367267). For Australian users: Stockopedia Ltd, ABN 39 757 874 670 is a Corporate Authorised Representative of Daylight Financial Group Pty Ltd ABN 77 633 984 773, AFSL 521404.